Skip to content

Clinical trials

Phase 2/3 Hypersensitivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 2/3 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20063
20071
20102
20111
20121
20131
20141
20162
20201
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status4
Withdrawn2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Artu Biologicals2
ALK-Abelló A/S1
AO GENERIUM1
Alexandria University1
Cairo University1
Circassia Limited1
Federal University of Pelotas1
Hospital General de Mexico1
Inmunotek S.L.1
Karolinska Institutet1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity18
Asthma3
Rhinitis3
Rhinitis, Allergic2
Anaphylaxis1
Angioedema1
Angioedemas, Hereditary1
Arthritis, Rheumatoid1
Bronchitis1
Conjunctivitis1

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.